The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials

Yoon, S; Kim, K; Shin, K; Kim, HS; Kim, B; Kim, MB; Ko, HC; Kim, YH

Ko, HC (通讯作者),Pusan Natl Univ, Dept Dermatol, Yangsan Hosp, 20 Geumo Ro, Yangsan 50612, South Korea.;Kim, YH (通讯作者),Pusan Natl Univ, Dept Anat, Dept Biomed Informat, Yangsan 50612, South Korea.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023; ():

Abstract

Janus kinase (JAK) inhibitors have been recently approved by the FDA and are widely used in the treatment of patients with atopic dermatitis. However,......

Full Text Link